Works matching IS 07703198 AND DT 2016 AND VI 35 AND IP 1


Results: 35
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients.

    Published in:
    Clinical Rheumatology, 2016, v. 35, n. 1, p. 219, doi. 10.1007/s10067-015-3135-3
    By:
    • Kojima, Toshihisa;
    • Takahashi, Nobunori;
    • Kaneko, Atsushi;
    • Kida, Daihei;
    • Hirano, Yuji;
    • Fujibayashi, Takayoshi;
    • Yabe, Yuichiro;
    • Takagi, Hideki;
    • Oguchi, Takeshi;
    • Miyake, Hiroyuki;
    • Kato, Takefumi;
    • Watanabe, Tsuyoshi;
    • Hayashi, Masatoshi;
    • Shioura, Tomone;
    • Kanayama, Yasuhide;
    • Funahashi, Koji;
    • Asai, Shuji;
    • Yoshioka, Yutaka;
    • Terabe, Kenya;
    • Takemoto, Toki
    Publication type:
    Article
    33
    34
    35